Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
Leiden, the Netherlands, October 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”)…
China International College Students’ Innovation Competition 2025 Finals Conclude in Zhengzhou
ZHENGZHOU, China, Oct. 20, 2025 /PRNewswire/ -- In a report published by Xinhua…
Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025
October 19, 2025 08:00 ET | Source: Replimune, Inc. WOBURN, Mass., Oct.…
Wialon Announces Top 10 GPS Hardware Manufacturers for 2025
DUBAI, UAE, Oct. 19, 2025 /PRNewswire/ -- Teltonika Telematics has once again been…
HKUST Holds Congregation 2025 Conferring Honorary Doctorates on Five Distinguished Leaders
HONG KONG, Oct. 18, 2025 /PRNewswire/ -- The Hong Kong University of…
Kaspersky Receives Frost & Sullivan’s 2025 META Competitive Strategy Leadership Recognition in Threat Prevention
The company is recognized for its operational excellence, stakeholder integration, and innovation…
Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platforms Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers…
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
Study data also showed prolonged progression-free survival with 177Lu-edotreotide compared to everolimus…
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
October 17, 2025 16:05 ET | Source: Jade Biosciences Presentations to highlight…
Dainik Bhaskar launches their latest ‘Sarthak Deepawali 2025’ campaign
AHMEDABAD, India, Oct. 17, 2025 /PRNewswire/ -- Every Diwali, Dainik Bhaskar's initiative 'Sarthak…
